tenatumomab
inotuzumab
duligotuzumab
tigatuzumab
naptumomab estafenatox
figitumumab
patritumab
drozitumab
conatumumab
acrixolimab
pamrevlumab
oleclumab
panitumumab
lexatumumab
lintuzumab
matuzumab
onartuzumab
adecatumumab
mapatumumab
nofetumomab
dalotuzumab
sibrotuzumab
durvalumab
inotuzumab ozogamicin
oportuzumab monatox
alacizumab
dacetuzumab
amivantamab
teprotumumab
avelumab
agonistic monoclonal antibody
ramucirumab
cixutumumab
apolizumab
catumaxomab
ertumaxomab
tabalumab
taplitumomab
cergutuzumab
samalizumab
siltuximab
atezolizumab
milatuzumab
robatumumab
volociximab
cantuzumab
minretumomab
-les-
carlumab
amatuximab